Delmas C - Search Results

1

The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.

Lemarié A, Lubrano V, Delmas C, Lusque A, Cerapio JP, Perrier M, Siegfried A, Arnauduc F, Nicaise Y, Dahan P, Filleron T, Mounier M, Toulas C, Cohen-Jonathan Moyal E. Lemarié A, et al. Among authors: delmas c. Sci Adv. 2023 Nov 3;9(44):eadi0114. doi: 10.1126/sciadv.adi0114. Epub 2023 Nov 3. Sci Adv. 2023. PMID: 37922359 Free PMC article. Clinical Trial.

2

Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation.

Delmas C, Heliez C, Cohen-Jonathan E, End D, Bonnet J, Favre G, Toulas C. Delmas C, et al. Int J Cancer. 2002 Jul 1;100(1):43-8. doi: 10.1002/ijc.10439. Int J Cancer. 2002. PMID: 12115585

3

RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.

Ader I, Toulas C, Dalenc F, Delmas C, Bonnet J, Cohen-Jonathan E, Favre G. Ader I, et al. Among authors: delmas c. Oncogene. 2002 Sep 5;21(39):5998-6006. doi: 10.1038/sj.onc.1205746. Oncogene. 2002. PMID: 12203112

4

Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells.

Dalenc F, Drouet J, Ader I, Delmas C, Rochaix P, Favre G, Cohen-Jonathan E, Toulas C. Dalenc F, et al. Among authors: delmas c. Int J Cancer. 2002 Aug 20;100(6):662-8. doi: 10.1002/ijc.10558. Int J Cancer. 2002. PMID: 12209603

5

Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts.

Ader I, Delmas C, Bonnet J, Rochaix P, Favre G, Toulas C, Cohen-Jonathan-Moyal E. Ader I, et al. Among authors: delmas c. Oncogene. 2003 Dec 4;22(55):8861-9. doi: 10.1038/sj.onc.1207095. Oncogene. 2003. PMID: 14654782

6

The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.

Delmas C, End D, Rochaix P, Favre G, Toulas C, Cohen-Jonathan E. Delmas C, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6062-8. Clin Cancer Res. 2003. PMID: 14676133

7

Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells.

Skuli N, Monferran S, Delmas C, Lajoie-Mazenc I, Favre G, Toulas C, Cohen-Jonathan-Moyal E. Skuli N, et al. Among authors: delmas c. Cancer Res. 2006 Jan 1;66(1):482-9. doi: 10.1158/0008-5472.CAN-05-2299. Cancer Res. 2006. PMID: 16397264

8

Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan-Moyal E, Toulas C. Monferran S, et al. Among authors: delmas c. Int J Cancer. 2008 Jul 15;123(2):357-364. doi: 10.1002/ijc.23498. Int J Cancer. 2008. PMID: 18464290

9

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.

Skuli N, Monferran S, Delmas C, Favre G, Bonnet J, Toulas C, Cohen-Jonathan Moyal E. Skuli N, et al. Among authors: delmas c. Cancer Res. 2009 Apr 15;69(8):3308-16. doi: 10.1158/0008-5472.CAN-08-2158. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351861

10

Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.

Lanvin O, Monferran S, Delmas C, Couderc B, Toulas C, Cohen-Jonathan-Moyal E. Lanvin O, et al. Among authors: delmas c. Eur J Cancer. 2013 Sep;49(13):2884-91. doi: 10.1016/j.ejca.2013.05.003. Epub 2013 Jun 6. Eur J Cancer. 2013. PMID: 23747271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters